SOURCE: Equity Leader Inc.

February 14, 2012 09:00 ET

Conditions of Growth, Economic Analysis - Research Report on Zynga Inc and Vertex Pharmaceuticals Incorporated

HONG KONG--(Marketwire - Feb 14, 2012) - Today, www.EquityLeader.com introduced research coverage of Zynga Inc (NASDAQ: ZNGA) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX). Full research reports are available to readers at: www.EquityLeader.com/index.php?sm1=ZNGA&sm2=VRTX.

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experienced in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Equity Leader has decided to cover Zynga Inc for its current position within the technology industry. Zynga Inc. (Zynga), formerly Presidio Media LLC, is a social game developer with 232 million average monthly active users (MAUs) in 166 countries. The Company's games are accessible on Facebook, other social networks and mobile platforms to players globally, wherever and whenever they want. It operates its games as live services. A copy of this report detailing Zynga Inc (NASDAQ: ZNGA) is available at: www.EquityLeader.com/index.php?sm1=ZNGA.

Equity Leader is also taking note of Vertex Pharmaceuticals Incorporated for its changing role within the healthcare industry. Vertex Pharmaceuticals Incorporated (Vertex) is engaged in the business of discovering, developing and commercializing small molecule drugs for the treatment of diseases. To download free research on Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) investors may visit: www.EquityLeader.com/index.php?sm2=VRTX.

About Equity Leader
Whether you are a first time investor or seasoned market professional, Equity Leader provides the resources necessary to simplify your research process. Our focus has always been to empower investors with the information they need to make their own investment decisions.

Contact Information